< Back to search
Filter
1

Adjuvant Quisinostat in High-Risk Uveal Melanoma

for
Uveal Melanoma
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 19+

Code: NCT06932757

Phase2, Recruiting

Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma

for
Locally Advanced or Metastatic Melanoma
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT05498792

Early_phase1, Recruiting

Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

for
Pancreatic Cancer, Melanoma,
Location: Houston TX
Sponsor: Threshold Pharmaceuticals

Sex: All

Age: 18+

Code: NCT03098160

Phase1, Recruiting

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: New York NY, Jacksonville FL, Cleveland OH,
Sponsor: GI Innovation, Inc.

Sex: All

Age: 18+

Code: NCT05824975

Phase1, Phase2, Recruiting

Pembrolizumab/Lenvatinib With and Without Healthy Donor FMT (hdFMT) in Relapsed/ Refractory (R/R) Melanoma

for
PD-1 Refractory Advanced Melanoma
Location: Pittsburgh PA
Sponsor: Diwakar Davar

Sex: All

Age: 18+

Code: NCT06030037

Phase2, Recruiting

Interested in new melanoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation

for
Metastatic Melanoma
Location: Houston TX, San Francisco CA
Sponsor: California Pacific Medical Center Research Institute

Sex: All

Age: 18+

Code: NCT04633902

Phase2, Recruiting

Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control

for
Melanoma (Skin), Non-melanomatous Skin Cancer
Location: Providence RI, Philadelphia PA, Columbus OH, Wichita KS,
Sponsor: Rhode Island Hospital

Sex: All

Age: 18+

Code: NCT00295906

Recruiting

Efficacy & Safety for LN144 with Pembrolizumab with High Risk Stage IIIb-dResectable Melanoma

for
Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IIID Melanoma
Location: Cleveland OH
Sponsor: James Isaacs, MD

Sex: All

Age: 18+

Code: NCT06190249

Phase1, Recruiting

FACE-Q in Facial Reconstructive Surgery: A Prospective Database

for
Skin Cancer, Basal Cell Skin Cancer Skin Cancer, Non-Melanoma Skin Cancers - Squamous Cell Carcinoma Patient Satisfaction,
Location: Hamilton
Sponsor: McMaster University

Sex: All

Age: 18 - 70+

Code: NCT04842279

Recruiting

A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers

for
Non-Melanoma Skin Cancers
Location: Charlotte NC
Sponsor: DermBiont, Inc.

Sex: All

Age: 18+

Code: NCT06409195

Phase2, Recruiting

The Role of Inflammation in Ocular Tumours

for
Ocular Melanoma
Location: Toronto
Sponsor: Unity Health Toronto

Sex: All

Age: 18+

Code: NCT02909517

Recruiting

Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation

for
Metastatic Melanoma
Location: San Francisco CA
Sponsor: California Pacific Medical Center Research Institute

Sex: All

Age: 18+

Code: NCT03925350

Phase2, Recruiting

Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors

for
Stage III Melanoma, Stage IV Melanoma
Location: Denver CO, Los Angeles CA
Sponsor: Taiga Biotechnologies, Inc.

Sex: All

Age: 18+

Code: NCT03385486

Phase1, Recruiting

A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

for
Uveal Melanoma
Location: San Francisco CA
Sponsor: California Pacific Medical Center Research Institute

Sex: All

Age: 18+

Code: NCT05077280

Phase2, Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

for
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma,
Location: Fairfax VA, Pittsburgh PA, Canton OH, Columbus OH,
Sponsor: OncoNano Medicine, Inc.

Sex: All

Age: 18+

Code: NCT06022029

Phase1, Recruiting

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

for
Solid Tumor, Adult, Triple Negative Breast Cancer,
Location: Scottsdale AZ, La Jolla CA, Stanford CA
Sponsor: BioEclipse Therapeutics

Sex: All

Age: 18+

Code: NCT04282044

Phase1, Recruiting

GI Complications in Cancer Immunotherapy Patients

for
Malignant Melanoma
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT02784366

Recruiting

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

for
Solid Tumor, Adult, Refractory Cancer,
Location: Boston MA, New Haven CT, New York NY, Fairfax VA,
Sponsor: GV20 Therapeutics

Sex: All

Age: 18+

Code: NCT05669430

Phase1, Phase2, Recruiting

The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

for
Non-Small-Cell Lung Carcinoma, Malignant Melanoma,
Location: Elizabethtown KY
Sponsor: VastBiome

Sex: All

Age: 18+

Code: NCT05037825

Recruiting

RAPA-201 Therapy of Solid Tumors

for
Solid Tumor, Small Cell and Non-small Cell Lung Cancer,
Location: Hackensack NJ
Sponsor: Rapa Therapeutics LLC

Sex: All

Age: 18+

Code: NCT05144698

Phase1, Phase2, Recruiting